147 related articles for article (PubMed ID: 33661188)
21. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
22. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
23. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
24. Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
Kim NH; Lee MY; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Yonsei Med J; 2017 Sep; 58(5):918-924. PubMed ID: 28792134
[TBL] [Abstract][Full Text] [Related]
25. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
Wang P; Li C; Ma X; Gai X
Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
[TBL] [Abstract][Full Text] [Related]
27. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
Elessawi DF; Alkady MM; Ibrahim IM
Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
30. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer.
Liu L; He Q; Li Y; Zhang B; Sun X; Shan J; Pan B; Zhang T; Zhao Z; Song X; Guo Y
Clin Chim Acta; 2020 Oct; 509():36-42. PubMed ID: 32502495
[TBL] [Abstract][Full Text] [Related]
31. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
Wang QJ; Zhang HC; Shen XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
[No Abstract] [Full Text] [Related]
33. Clinical significance of serum IGFBP-3 in colorectal cancer.
Hou YL; Luo P; Ji GY; Chen H
J Clin Lab Anal; 2019 Jul; 33(6):e22912. PubMed ID: 31218761
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
Karlíková M; Čurillová M; Pecen L; Karnos V; Karnos V; Topolčan O
Anticancer Res; 2024 Jul; 44(7):3105-3113. PubMed ID: 38925804
[TBL] [Abstract][Full Text] [Related]
35. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
36. Serum CEA and CA19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
Zhai H; Huang J; Yang C; Fu Y; Yang B
Clin Lab; 2018 Mar; 64(3):351-356. PubMed ID: 29739122
[TBL] [Abstract][Full Text] [Related]
37. [Construction of a fecal protein Luminex liquid chip detection system for early diagnosis of colorectal tumors].
Li J; Yin L; Zhang M; Xia Y; Zuo L; Liu M; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1874-1880. PubMed ID: 38081604
[TBL] [Abstract][Full Text] [Related]
38. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
39. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
Pasha HF; Radwan MI; Yehia AM; Toam MM
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
[TBL] [Abstract][Full Text] [Related]
40. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]